Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Green Jeremy
Relationship:   Former 10% Owner and D...
City:   San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   31    
Direct Shares   49,793    

Indirect Shares

   116,486,068      
Direct Value   $248,965    

Indirect Value

   $308,148,830      
Total Shares   116,535,861      
Total Value   $308,397,795      


Syros Pharmaceuticals, Inc. $248,965 Syros Pharmaceuticals, Inc. $248,965
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    9   
    1    

     Stock price went up :
    1   
    0    
     Stock price went down :
    8   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
   -16.9%
 -38.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Amicus Therapeutics Inc FOLD 10% Owner 2016-06-03 0 2016-06-03 12,956,446    Premium*  
            Syros Pharmaceuticals, Inc. SYRS 10% Owner 2016-07-06 49,793 2016-07-06 0    Premium*  
            Xeris Pharmaceuticals Inc XERS 10% Owner 2018-06-25 0 2019-02-19 3,000,642    Premium*  
            Allakos Inc. ALLK 10% Owner 2018-07-23 0 2018-07-23 1,009,090    Premium*  
            Replimune Group Inc REPL 10% Owner 2018-07-24 0 2018-07-24 779,655    Premium*  
            Fate Therapeutics Inc FATE Director, 10% Owner 2018-09-25 0 2023-12-26 13,180,388    Premium*  
            Gritstone Oncology, Inc. GRTS 10% Owner 2018-10-02 0 2018-10-02 1,394,529    Premium*  
            Vapotherm Inc VAPO 10% Owner 2018-11-16 0 2018-11-16 959,540    Premium*  
            Tcr2 Therapeutics Inc. TCRR 10% Owner 2019-02-19 0 2019-02-19 807,256    Premium*  
            Alder Biopharmaceuticals Inc ALDR Director 2019-03-04 0 2019-10-22 0    Premium*  
            Akero Therapeutics, Inc. AKRO 10% Owner 2019-06-24 0 2019-06-24 743,802    Premium*  
            Atreca Inc BCEL 10% Owner 2019-06-24 0 2019-06-24 715,306    Premium*  
            Stoke Therapeutics, Inc. STOK 10% Owner 2019-06-21 0 2019-06-21 671,808    Premium*  
            Igm Biosciences, Inc. IGMS 10% Owner 2019-09-20 0 2024-03-29 3,078,332    Premium*  
            Aprea Therapeutics, Inc. APRE 10% Owner 2019-10-07 0 2020-12-28 1,768,718    Premium*  
            Cabaletta Bio, Inc. CABA 10% Owner 2019-10-29 0 2019-10-29 696,378    Premium*  
            Beam Therapeutics Inc. BEAM 10% Owner 2020-02-10 0 2020-02-10 1,161,458    Premium*  
            Neurogene NGNE 10% Owner 2020-03-27 0 2020-04-02 4,041,211    Premium*  
            Pliant Therapeutics, Inc. PLRX 10% Owner 2020-06-05 0 2020-06-05 1,910,657    Premium*  
            Repare Therapeutics Inc. RPTX 10% Owner 2020-06-23 0 2020-06-23 1,586,174    Premium*  
            Nurix Therapeutics, Inc. NRIX 10% Owner 2020-07-28 0 2020-07-28 1,176,470    Premium*  
            Annexon, Inc. ANNX 10% Owner 2020-07-28 0 2020-07-28 1,596,222    Premium*  
            Allovir Inc ALVR 10% Owner 2020-08-03 0 2020-08-03 823,371    Premium*  
            Kymera Therapeutics, Inc. KYMR 10% Owner 2020-08-25 0 2020-08-25 1,630,660    Premium*  
            Augmedix, Inc AUGX Director, 10% Owner 2020-10-05 0 2024-03-15 16,408,909    Premium*  
            Shattuck Labs, Inc. STTK Director, 10% Owner 2020-10-14 0 2024-03-28 5,615,489    Premium*  
            MedAvail Holdings, Inc MDVL Director, 10% Owner 0 2022-04-04 25,192,751    Premium*  
            Verve Therapeutics, Inc. VERV 10% Owner 2021-06-21 0 2021-06-21 1,936,530    Premium*  
            Absci Corp ABSI Director 2021-07-26 0 2024-03-01 8,253,316    Premium*  
            Adagio Therapeutics, Inc. ADGI 10% Owner 2021-08-10 0 2021-08-10 3,390,960    Premium*  
            Science 37 Holdings, Inc SNCE Former 10% Owner and D... 2021-10-06 0 2024-03-12 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
FATE Fate Therapeutics Inc Director   –       •       •   2021-01-08 4 B $85.50 $27,999,968 I/I 327,485 12,957,222 2.25 %
IGMS Igm Biosciences, Inc. Director   –       •       •   2020-09-09 4 B $51.85 $1,222,335 I/I 23,260 3,425,811 2.25 -
IGMS Igm Biosciences, Inc. Director   –       •       •   2020-09-04 4 B $50.28 $3,742,186 I/I 74,433 3,355,438 2.25 -
IGMS Igm Biosciences, Inc. Director   –       •       •   2020-09-08 4 B $49.91 $2,351,504 I/I 47,113 3,402,551 2.25 -
IGMS Igm Biosciences, Inc. Director   –       •       •   2020-09-03 4 B $48.69 $3,615,208 I/I 74,253 3,281,005 2.25 -
IGMS Igm Biosciences, Inc. Director   –       •       •   2020-09-02 4 B $45.54 $963,267 I/I 20,637 3,206,752 2.25 -
IGMS Igm Biosciences, Inc. Director   –       •       •   2020-09-01 4 B $44.84 $1,872,327 I/I 41,759 3,186,115 2.25 -
FATE Fate Therapeutics Inc Director   –       •       •   2020-06-11 4 B $28.31 $39,999,992 I/I 1,412,928 12,629,737 2.25 %
IGMS Igm Biosciences, Inc. 10% Owner   –       –       •   2022-10-03 4 A $22.49 $4,971,909 I/I 221,072 3,336,277 0 -
IGMS Igm Biosciences, Inc. 10% Owner   –       –       •   2022-10-03 4 D $22.49 $4,971,909 I/I (221,072) 3,336,277 0 -
VERV Verve Therapeutics, Inc. 10% Owner   –       –       •   2021-06-21 4 B $19.00 $19,950,000 I/I 1,050,000 1,936,530 1.5 -
FATE Fate Therapeutics Inc Director   –       •       •   2019-09-16 4 B $17.50 $15,000,003 I/I 857,143 11,216,809 2.25 -
STTK Shattuck Labs, Inc. Director   –       •       •   2020-10-14 4 B $17.00 $59,669,343 I/I 3,441,176 5,619,914 2.25 -
ADGI Adagio Therapeutics, Inc. 10% Owner   –       –       •   2021-08-10 4 B $17.00 $24,990,000 I/I 1,470,000 3,390,960 1.5 %
IGMS Igm Biosciences, Inc. Director   –       •       •   2019-09-20 4 A $16.00 $50,304,000 I/I 3,144,000 3,144,000 0 -
ABSI Absci Corp Director   –       •      –    2021-07-26 4 B $16.00 $30,000,000 I/I 1,875,000 8,031,094 2.1 %
XERS Xeris Pharmaceuticals Inc   •       •       •   2018-06-25 4 B $15.00 $10,000,020 I/I 666,668 2,412,642 0.01 -
APRE Aprea Therapeutics, Inc. 10% Owner   –       –       •   2019-10-07 4 B $15.00 $6,000,000 I/I 400,000 2,268,718 1.5 -
FATE Fate Therapeutics Inc Director   –       •       •   2018-09-25 4 B $13.50 $50,000,004 I/I 3,703,704 10,359,666 2.25 -
SYRS Syros Pharmaceuticals, In... 10% Owner   –       –       •   2016-07-06 4 B $12.50 $5,409,325 D/D 432,746 49,793 2.45 -
ALDR Alder Biopharmaceuticals ... 10% Owner   –       –       •   2019-03-04 4 A $11.50 $19,999,995 I/I 1,739,130 8,244,896 0 -
NGNE Neurogene 10% Owner   –       –       •   2020-04-02 4 B $11.36 $446,958 I/I 39,300 4,051,045 1.5 -
NGNE Neurogene 10% Owner   –       –       •   2020-04-02 4 S $11.30 $111,214 I/I (9,834) 4,041,211 0 -
NGNE Neurogene 10% Owner   –       –       •   2020-04-01 4 S $11.06 $108,940 I/I (9,834) 4,011,745 0 -
NGNE Neurogene 10% Owner   –       –       •   2020-04-01 4 B $10.95 $471,630 I/I 42,500 4,021,579 1.5 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us